| Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma E Cantor, K Wierzbicki, RS Tarapore, K Ravi, C Thomas, R Cartaxo, ... Neuro-oncology 24 (8), 1366-1374, 2022 | 50 | 2022 |
| Targeting and therapeutic monitoring of H3K27M-mutant glioma K Wierzbicki, K Ravi, A Franson, A Bruzek, E Cantor, M Harris, MJ Homan, ... Current oncology reports 22, 1-9, 2020 | 46 | 2020 |
| Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha, M Mota, M Pun, ... Cancer discovery 13 (11), 2370-2393, 2023 | 31 | 2023 |
| Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma AK Bruzek, K Ravi, A Muruganand, J Wadden, CM Babila, E Cantor, ... Clinical Cancer Research 26 (23), 6266-6276, 2020 | 29 | 2020 |
| Astrocytes in rare neurological conditions: Morphological and functional considerations K Ravi, MJ Paidas, A Saad, AR Jayakumar Journal of Comparative Neurology 529 (10), 2676-2705, 2021 | 21 | 2021 |
| Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model MJ Homan, A Franson, K Ravi, H Roberts, MP Pai, C Liu, M He, ... Cancer chemotherapy and pharmacology 88, 555-562, 2021 | 19 | 2021 |
| Cell-free tumor DNA (cf-tDNA) liquid biopsy: Current methods and use in brain tumor immunotherapy J Wadden, K Ravi, V John, CM Babila, C Koschmann Frontiers in Immunology 13, 882452, 2022 | 12 | 2022 |
| Comparative analysis of racial and gender diversity in orthopedic surgery applicants and residents from 2007 and 2019 AC Onuoha, AM Meadows, MT Faraj, MM Skinner, C Day, K Ravi Journal of Orthopaedic Experience & Innovation, 2022 | 11 | 2022 |
| Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice K Ravi, A Franson, MJ Homan, H Roberts, MP Pai, Z Miklja, M He, B Wen, ... Leukemia & lymphoma 62 (8), 1990-1994, 2021 | 10 | 2021 |
| CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA AR Kawakibi, R Tarapore, S Gardner, A Chi, S Kurz, PY Wen, ... Neuro-Oncology 24 (Supplement_7), vii86-vii87, 2022 | 3 | 2022 |
| Manufacturing workers have a higher incidence of carpal tunnel syndrome EB Battista, NR Yedulla, DS Koolmees, ZA Montgomery, K Ravi, CS Day Journal of occupational and environmental medicine 63 (3), e120-e126, 2021 | 3 | 2021 |
| Upregulation of the Ribosomal Pathway as a Potential Blood-Based Genetic Biomarker for Comorbid Major Depressive Disorder (MDD) and PTSD K Ravi, I Lee Journal of Emerging Investigators, 2018 | 2 | 2018 |
| Expanding Access to CNS-TAP: Design, Development, and Initial Use of a Complex Precision Health Specialty Web App for Neuro-Oncology K Ravi, G Meng, HJ Roberts, A Schepers, A Franson, C Koschmann, ... Studies in health technology and informatics 290, 804, 2022 | 1 | 2022 |
| Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications MC Jin, ID Connolly, K Ravi, DG Tobert, SM MacDonald, JH Shin Neurosurgical Focus 56 (5), E18, 2024 | | 2024 |
| Predicting CNS penetration of precision medicine therapies in oncology: A comparison of the CNS TAP tool and the BOILED-Egg computational model. G Walker, AF Franson, M Pai, K Ravi, H Roberts, A Schepers, ... Journal of Clinical Oncology 40 (16_suppl), 2062-2062, 2022 | | 2022 |
| BIOM-28. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (cf-tDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201 E Cantor, K Wierzbicki, R Tarapore, K Ravi, J Wadden, C Babilla, ... Neuro-Oncology 23 (Supplement_6), vi16-vi17, 2021 | | 2021 |
| CNS-TAP TOOL RECOMMENDATIONS OF TARGETED ANTI-CANCER AGENTS COMPARED TO THOSE SELECTED BY A MULTIDISCIPLINARY TUMOR BOARD IN A MOLECULARLY-DRIVEN DIPG CLINICAL TRIAL (PNOC003) H Roberts, K Ravi, A Schepers, B Marini, C Kline, S Mueller, ... NEURO-ONCOLOGY 23, 108-108, 2021 | | 2021 |
| CLRM-06. COMPARISON OF INDIVIDUALIZED ANTI-CANCER THERAPY REGIMENS RECOMMENDED BY A MULTIDISCIPLINARY MOLECULARLY-DRIVEN TUMOR BOARD IN A PEDIATRIC DIPG CLINICAL TRIAL (PNOC003 … H Roberts, K Ravi, A Schepers, B Marini, C Kline, S Mueller, ... Neuro-Oncology Advances 3 (Supplement_4), iv2-iv2, 2021 | | 2021 |
| EPCT-02. COMPARISON OF TARGETED AGENTS RECOMMENDED BY THE CNS-TAP TOOL TO THOSE SELECTED BY A TUMOR BOARD IN A MOLECULARLY-DRIVEN DIPG CLINICAL TRIAL H Roberts, K Ravi, B Marini, C Kline, S Mueller, C Koschmann, A Franson Neuro-oncology 23 (Suppl 1), i46, 2021 | | 2021 |
| Targeted agents recommended by the CNS TAP tool compared to those selected by a tumor board in a molecularly-driven clinical trial in children and young adults with DIPG. H Roberts, K Ravi, C Kline, S Mueller, CJ Koschmann, B Marini, ... Journal of Clinical Oncology 39 (15_suppl), 2048-2048, 2021 | | 2021 |
